Hemodialysis fistulas and grafts: use of cutting balloons to dilate venous stenoses

Radiology
D VorwerkR W Guenther

Abstract

To evaluate percutaneous transluminal angioplasty (PTA) with a cutting balloon performed in stenosed hemodialysis fistulas and grafts, 19 venous lesions in 15 patients were treated with a cutting balloon with an inflated diameter of 3-6 mm. The grade of stenosis ranged from 40% to 90% (mean, 65% +/- 15 [standard deviation]). Cutting PTA was performed before conventional PTA in seven patients and was followed with conventional PTA with larger balloons in seven patients. The balloon expanded completely in all patients, and no balloon waist remained. The mean grade of stenosis decreased to 14% +/- 9. Cutting PTA increased the technical success of balloon dilation of hemodialysis fistulas and grafts.

Citations

Aug 20, 2002·AJR. American Journal of Roentgenology·Christoph EngelkeAnna-Maria Belli
Mar 21, 2003·AJR. American Journal of Roentgenology·J Mark RyanTony P Smith
Jul 2, 2010·Journal of Endourology·Ugur BoyluRaju Thomas
Mar 12, 2005·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Gerlinde Tynan-Cuisiner, Scott S Berman
Apr 13, 2006·European Radiology·Dimitrios TsetisAnna-Maria Belli
May 12, 2005·Cardiovascular and Interventional Radiology·Levent OguzkurtRiza Turkoz
Jul 13, 2005·Cardiovascular and Interventional Radiology·S ChakravertyG D Griffiths
Jul 22, 2005·Cardiovascular and Interventional Radiology·Manfred Cejna
Sep 15, 2005·Cardiovascular and Interventional Radiology·Aalpen A PatelScott O Trerotola
Jan 6, 2007·Cardiovascular and Interventional Radiology·Jan H Peregrin, Miloslav Rocek
Dec 24, 2013·Annals of Vascular Surgery·Alexandros MalliosWilliam C Jennings
Dec 24, 2005·Journal of Vascular and Interventional Radiology : JVIR·Scott O TrerotolaJesse L Chittams
Dec 24, 2005·Journal of Vascular and Interventional Radiology : JVIR·Thomas M Vesely, Jeffrey B Siegel
Dec 14, 2004·Journal of Vascular and Interventional Radiology : JVIR·Ha-Hun SongSun-Ae Yoon
Jan 11, 2005·Journal of Vascular and Interventional Radiology : JVIR·Brian Funaki
Jan 11, 2005·Journal of Vascular and Interventional Radiology : JVIR·Jonathan Singer-Jordan, Sorin Papura
May 28, 2008·Journal of Vascular and Interventional Radiology : JVIR·Chih-Cheng WuSzu-Chi Wen
Aug 7, 2007·Journal of Vascular and Interventional Radiology : JVIR·Boris GuiuDenis Krausé
Mar 5, 2002·Journal of Vascular and Interventional Radiology : JVIR·Graham J MunnekeAnna-Maria Belli
Nov 9, 2005·Journal of Vascular Surgery·Tommaso LupattelliLuigi Inglese
Jan 22, 2005·Seminars in Dialysis·Vijay P SreenarasimhaiahSteven J Bander
Jan 14, 2004·Seminars in Dialysis·Timothy W I Clark, Dheeraj K Rajan
Sep 28, 2007·Seminars in Dialysis·Shahriar MoossaviBarry I Freedman
Sep 4, 2007·Journal of Vascular Surgery·Robert Garvin, Thomas Reifsnyder
Dec 3, 2008·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·R MofidiP A Stonebridge
Apr 23, 2008·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·Dimitrios TsetisNicholas Gourtsoyiannis
Nov 22, 2005·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·P Haage, R W Günther
Jun 27, 2002·Advances in Renal Replacement Therapy·Thomas M Vesely
Nov 16, 2013·Clinical Journal of the American Society of Nephrology : CJASN·Christi M Terry, Laura M Dember
May 23, 2018·International Journal of Vascular Medicine·Ioannis BountourisKonstantinos Ioannis Avgerinos

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.